Efficacy and safety evaluation of Venetoclax combined with homoharringtonine regimen in the treatment of patients with refractory and relapsed acute myeloid leukemia

Panminerva Med. 2024 Feb 27. doi: 10.23736/S0031-0808.24.05064-X. Online ahead of print.NO ABSTRACTPMID:38411405 | DOI:10.23736/S0031-0808.24.05064-X

Source: Panminerva Medica - February 27, 2024 Category: General Medicine Authors: Mingxia Wei Xuliang Shen Chunyan Zhai Wenyu Gao Source Type: research